ExploreWatchlistsPricing
  1. US-listed companies
  2. Cyclo Therapeutics, Inc.
  3. Financials
  4. Operating margin (%)

Cyclo Therapeutics, Inc. (CYTH)

Market cap
$20.73M
P/E ratio
SummaryFinancials
Period EndOperating margin (%) YoY (%)
Dec 31, 2023-1,862.7+64.04%
Dec 31, 2022-1,135.5+26.01%
Dec 31, 2021-901.2-9.16%
Dec 31, 2020-992+32.43%
Dec 31, 2019-749.1+77.57%
Dec 31, 2018-421.8+35.85%
Dec 31, 2017-310.5+10.95%
Dec 31, 2016-279.8+10.52%
Dec 31, 2015-253.2+605.85%
Dec 31, 2014-35.9-280.45%
Dec 31, 201319.9+31.91%
Dec 31, 201215.1-309.43%
Dec 31, 2011-7.2

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat